| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5dd388a5130b0bdede0fdfc6c2af6ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c78538669e9a60fdea50fbe37f6814a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145 |
| filingDate |
2015-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df98292f85acad9e27620953791ff252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_378391da3c4ce74669e6bb3c94679213
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ddfc32683317effd0d677e148a11a47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_945b36b0a336441da926a24e374cd988
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1ac91687bfb11bc5388322e547af98e |
| publicationDate |
2016-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016100926-A1 |
| titleOfInvention |
Synergistic co-administration of computationally optimized broadly reactive antigens for human and avian h5n1 influenza |
| abstract |
The present invention provides co-administration (e.g., immunogenic cocktail and/or prime-boost regimens) of computationally optimized H5N 1 influenza hemagglutinin (HA) polypeptides that. Co-administration of the optimized H5N 1 influenza hemagglutinin (HA) polypeptides facilitates synergistic neutralization of viral infection and provides for improved protective immunity (e.g., a broad reactive immune response) to multiple H5N 1 influenza virus clades and strains. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10844097-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016196846-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018073340-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3876983-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020014673-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10584148-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11325947-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017210599-A1 |
| priorityDate |
2014-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |